STAT+: Louisiana, Oregon deals show health insurer acquisitions aren’t a sure thing anymore
A deal is never really done until it’s done. On Tuesday, two different proposed insurance…
Category: Medicine
STAT+: Pharmalittle: We’re reading about kids taking Wegovy, telehealth for abortion pills, and more
And so, another working week will soon draw to a close. Not a moment too…
Alnylam thickened the plot
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: I’ve reported on the health of every president since Reagan. Here’s what I think about Trump and Biden
When I interviewed Ronald Reagan about his health in 1980, he was 69 and poised…
Solving astronauts’ health challenges in deep space could have payoffs on Earth
Space is famously known as the final frontier for human exploration. It may also be…
STAT+: For unlucky mountaineers, tundra explorers and the unhoused, a new drug could avert the ravages of frostbite
Two days after his right hand froze, Hart Bezner realized for the first time that…
HHS fills key vaccine advisory panel slots
The Department of Health and Human Services announced Thursday that it is filling eight vacancies,…
Listen: Pharma goes to Washington, Alnylam’s future, & Gilead’s dealmaking
Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next…
Covid-19 vaccine confidence soured by officials’ messaging, Republicans argue
WASHINGTON — A House hearing on vaccine safety claims sought to pierce through Americans’ falling…
STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound
The Food and Drug Administration is cracking down on websites that claim to sell the…
STAT+: Sick patients collapsed waiting for care at Mass. hospital with known safety violations
Struggling to breathe, the patient stepped out of the registration line in the hospital’s overwhelmed…
.jpg)
Lyme disease cases rise, but largely due to a change in data collection
A new report released Thursday by the Centers for Disease Control and Prevention appears to…
STAT+: Hospital claims it was ‘drastically’ overcharged by pharma in a federal drug discount program
For several years, some of the world’s largest pharmaceutical companies that participate in a U.S….
Abortion pills offered via telehealth as safe as in-person medication abortions, study finds
With the Supreme Court just a month away from hearing arguments over access to the…
American Medical Association’s digital advisors table RPM coding reform proposal, again
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
Pharma’s contractors might finally be on the rebound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a FTC probe into GPOs, a frostbite drug, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Gaming Amylyx stock reactions to the next ALS drug test, and a chat with CRISPR’s CEO about a new investor
This week, a preview of the TUDCA study in ALS and thoughts on how it…
Opinion: Independent doctors like me are becoming an endangered species
More than 100,000 doctors have left private practice and become employees of hospitals and other corporate entities since…
Juul’s internal playbook opens a rare window into influence in Washington
WASHINGTON — A new trove of internal emails and other documents from the e-cigarette maker…
Long Covid research funding at NIH gets a nearly 50% boost
WASHINGTON — The Biden administration has dedicated an additional $515 million to a major initiative…
STAT+: Leaked version of EFTA-India free trade deal sparks alarm over access to medicines
A leaked version of a proposed agreement between India and the European Free Trade Association…
STAT+: The Jewish American and Palestinian American scientists who’ve been partnering for 14 years on science’s toughest challenges
WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads…
STAT+: FTC to probe the role of middlemen in worsening drug shortage crisis
The Federal Trade Commission is launching a probe into the extent to which group purchasing…
STAT+: Digital tools helped lower blood pressure in marginalized patient groups
If you have high blood pressure, it’s increasingly likely that your doctor or your insurer…
Smoking impairs immune response, even after quitting, new study says
Public health messages have told us for decades that if you smoke, you should quit….
STAT+: Pharmalittle: We’re reading about slow uptake of an Alzheimer’s drug, an opioid lawsuit, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
Replicate’s srRNA rabies vaccine effective in Phase 1
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Biotech launches with $135 million for Vertex-competing pain medicine
After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched…
Opinion: The health care system is ignoring world’s most promising approach to preventing cardiovascular disease
Last week, the Washington Post published an op-ed by former CDC Director Tom Frieden titled,…
Opinion: STAT+: A year in, the U.S. is still not taking advantage of lower-cost biosimilars for Humira
It’s been one year since the launch of the first adalimumab biosimilar for Humira in…
STAT+: FDA advisory panel votes in favor of Abbott’s new heart device
An advisory panel to the Food and Drug Administration voted in favor of a new…
STAT+: Lawmakers eye partial increase for Medicare doctor pay
WASHINGTON — Lawmakers are considering increasing doctors’ Medicare pay in an upcoming government funding package,…
.jpg)
STAT+: Private equity investment in Medicare Advantage drops
Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing…
STAT+: Biogen Alzheimer’s drug launch off to slow start
Seven months after US drug regulators fully approved Biogen’s treatment for Alzheimer’s disease, only about…
The need to know biotech news stories today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a tossed PhRMA lawsuit, secrecy clauses, and more
Rise and shine, everyone, another busy day is on the way. However, the pace this…
STAT+: Startup BioAge raises $170 million Series D for Zepbound combination therapy
A California biotech developing a combination therapy with the obesity drug Zepbound has raised a…
STAT+: KalVista pill reduces swelling symptoms caused by genetic disease, achieving goal of late-stage study
KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced…
Opinion: STAT+: A California court is setting a dangerous precedent over drug development (or lack thereof) liability
The assault on the development of new lifesaving therapies continues apace. Recently, the First Appellate…
Was Pfizer’s “Here’s to Science” commercial during the Super Bowl a winning play or a fumble?
Super Bowl ads are a show within the show, an opportunity for brands and advertising…
STAT+: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices
WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss…
No one’s pleased with the government’s pitch for 2025 Medicare Advantage rates
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
Stem cell study offers clue to South Asians’ increased risk of cardiovascular disease
A growing body of data show that South Asians are at greater risk of developing…
Ebola vaccine cuts fatality even in people who were infected before the jab, new study shows
A new study has shown that people vaccinated against Ebola who still developed the disease…
STAT+: Gilead to acquire CymaBay for $4.3 billion, adding new treatment for liver disease
Gilead Sciences said Monday it will acquire CymaBay Therapeutics for $4.3 billion, adding a new…
Psychedelic investment continues to ramp up
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Moderna’s RSV vaccine, Aurobindo problems, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Dental care is in crisis. But it’s also a moment of opportunity
While staffing crises at hospitals continue to make headlines, dental care — too often overlooked…
STAT+: A flurry of research misconduct cases has universities scrambling to protect themselves
There was a time when an allegation of data mishandling, scientific misconduct, or just a…